Previous Close | 0.0000 |
Open | 0.7400 |
Bid | 0.0005 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.7400 - 0.7400 |
52 Week Range | 0.5600 - 0.8100 |
Volume | |
Avg. Volume | 48 |
Market Cap | 48.37M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4000 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SASKATOON, Saskatchewan, September 28, 2024--ZYUS Life Sciences Corporation (the "Company") (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announces that an independent director of the Company (the "Lender") has agreed to advance a CAD$1,000,000 unsecured loan (the "Loan") to the Company with a closing date on or about October 1, 2024 and subject to the Company f
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...